Realtime Diagnosis From Electrocardiogram Artificial Intelligence-Guided Screening for Atrial Fibrillation With Long Follow-Up (REGAL)

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 5 months later Sep 2026 → Mar 2028
See other at-risk trials from Mayo Clinic

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Sep 2026 to Mar 2028
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: details revised at 2 of 5 entries
    • Publications: details revised at 1 of 1 entry
  2. Trial status: Enrolling by Invitation to Active, Not Recruitingv8
  3. Re-verified, no change to tracked fieldsv7
  4. Start date changed from estimate of Apr 2024 to Apr 10, 2024v6
  5. Start date: Feb 2024 to Apr 2024v5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Nov 2023 to Feb 2024v4
  2. Start date: Sep 2023 to Nov 2023v3
  3. Study title expanded, about 4 wordsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,024 trials monitored
See 128 trials at risk
Heart Disease
8,814 trials monitored
See 428 trials at risk
Atrial Fibrillation
1,188 trials monitored
See 57 trials at risk
The purpose of this research is to test whether Apple Watch, used as a long-term monitoring device, can enable early detection of atrial fibrillation.
Trial Details
NCT Number NCT05923359
Lead Sponsor Mayo Clinic
Conditions
(from sponsor)		 Atrial Fibrillation
Related terms Atrial Fibrillation
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov